Case report: Dementia sensitivity to altitude changes and effective treatment with hyperbaric air and glutathione precursors.
| Autor: | Fogarty EF; MoPlatte Sports Medicine, Ogallala, NE, United States., Harch PG; LSU Health Sciences Center, New Orleans, LA, United States. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Frontiers in neurology [Front Neurol] 2024 Jun 19; Vol. 15, pp. 1356662. Date of Electronic Publication: 2024 Jun 19 (Print Publication: 2024). |
| DOI: | 10.3389/fneur.2024.1356662 |
| Abstrakt: | A 78-year-old man with dementia experienced waxing and waning of symptoms with changes in altitude as he traveled from his home in the Rocky Mountains to lower elevations and back. To replicate the improvement in his symptoms with travel to lower elevations (higher pressure), the patient was treated with a near-identical repressurization in a hyperbaric chamber using compressed air. With four 1-h treatments at 1.3 Atmospheres Absolute (ATA) and concurrent administration of low-dose oral glutathione amino acid precursors, he recovered speech and showed improvement in activities of daily living. Regional broadcast media had documented his novel recovery. Nosocomial COVID-19 and withdrawal of hyperbaric air therapy led to patient demise 7 months after initiation of treatment. It is theorized that hyperbaric air therapy stimulated mitochondrial biochemical and physical changes, which led to clinical improvement. Competing Interests: EF owns multiple hyperbaric chambers and medical imaging devices used in his practice of clinical medicine. From 2016 to 2020, MoPlatte Sports Medicine was the entity under which EF was a distributor for The ProImmune Company, LLC. EF remains a consultant to the inventor of ProImmune Immune Formulation 200, Albert B. Crum, MD (ABC). ABC's Canadian Patent (https://www.ic.gc.ca/opic-cipo/cpd/eng/patent/2963131/summary.html?) was a primary reference for the North Dakota CARES ACT Grant Committee approval of EFF's natropathic/medical countermeasures for COVID19 covered under the United States Federal PREP ACT of 2020. EF is a consultant for Joseph V. Cassarino, the current distributor of ProImmune Immune Formulation 200 at www.theBestImmuneSupport.com which has provided partial funding support in conjunction with the North Dakota CARES ACT grant support for the broadcasting of the hyperbaric and GSH pre-cursor medical countermeasures to COVID19 developed through EFF's clinical experience in this case on the following FCC regulated communications platforms: KFYR, KXEL, KCRO, WXJB, and KXNET. PH is the owner of an S Corporation that is the vehicle for his practice of hyperbaric medicine. He also performs consulting and gives expert witness testimony under this S Corp. (Copyright © 2024 Fogarty and Harch.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|